相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heterogeneous HER2 Gene Amplification Impact on Patient Outcome and a Clinically Relevant Definition
Alastair I. Bartlett et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer
Agnieszka Jagiello-Gruszfeld et al.
ONCOLOGY (2010)
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
Gulisa Turashvili et al.
BMC CANCER (2009)
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases
Zenonas Theodosiou et al.
BREAST (2008)
A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals
J. Konsti et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast - A single institution experience
Raymond R. Tubbs et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
Standardization of HER2 testing:: results of an international proficiency-testing ring study
Mitch Dowsett et al.
MODERN PATHOLOGY (2007)
Intratumoral heterogeneity of HER2/neu in breast cancer -: A rare event
Wedad Hanna et al.
BREAST JOURNAL (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intratumoral heterogeneity of HER-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray
Sandra J. Shin et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2006)
HER2 and responsiveness of breast cancer to adjuvant chemotherapy
KI Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Marked intratumoral heterogeneity of c-myc and CyclinD1 but not of c-erbB2 amplification in breast cancer
S Glöckner et al.
LABORATORY INVESTIGATION (2002)
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
G Pauletti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
